03:32:18 EDT Wed 30 Apr 2025
Enter Symbol
or Name
USA
CA



EnWave Corp
Symbol ENW
Shares Issued 111,090,055
Close 2025-03-27 C$ 0.26
Market Cap C$ 28,883,414
Recent Sedar Documents

EnWave signs master service agreement with BioTechnique

2025-03-27 17:38 ET - News Release

Mr. Brent Charleton reports

ENWAVE SIGNS MASTER SERVICE AGREEMENT AND FIRST WORK ORDER WITH BIOTECHNIQUE LLC

EnWave Corp. has signed a master service agreement with BioTechnique, an American pharmaceutical contract manufacturing service provider. This agreement outlines the terms for the continued evaluation by BioTechnique of EnWave's radiant energy vacuum (REV) dehydration technology as a suitable replacement for lyophilization in the biopharmaceutical industry.

The first anticipated collaboration will include paid testing of several liquid products to be dried in vials using pilot-scale REV machinery at EnWave's innovation centre in Delta, B.C. If deemed successful, BioTechnique may decide to acquire their own REV equipment for service provision directly for their client base of leading pharmaceutical companies.

About BioTechnique LLC

BioTechnique is an American pharmaceutical contract research, development and manufacturing facility filling the need for therapeutic and highly potent sterile injectable products -- both liquid and lyophilized. BioTechnique's filling lines can handle both clinical and commercial batches.

BioTechnique's project management and client services staff work closely with their clients to provide services for formulation and compounding, QC (quality control) testing, temperature-controlled storage, fill-finish, and lyophilization for a wide variety of injectable products.

About EnWave Corp.

EnWave is a global leader in the innovation and application of vacuum microwave dehydration. From its headquarters in Delta, B.C., EnWave has developed a robust intellectual property portfolio, perfected its radiant energy vacuum (REV) technology and transformed an innovative idea into a proven, consistent and scalable drying solution for the food, pharmaceutical and cannabis industries that vastly outperforms traditional drying methods in efficiency, capacity, product quality and cost.

With more than 50 partners spanning 24 countries and five continents, EnWave's licensed partners are creating profitable, never-before-seen snacks and ingredients, improving the quality and consistency of their existing offerings, running leaner and getting to market faster with the company's patented technology, licensed machinery and expert guidance.

EnWave's strategy is to sign royalty-bearing commercial licences with food producers who want to dry better, faster and more economical than freeze drying, rack drying and air drying, and enjoy the following benefits of producing exciting new products, reaching optimal moisture levels up to seven times faster, and improve product taste, texture, colour and nutritional value.

We seek Safe Harbor.

© 2025 Canjex Publishing Ltd. All rights reserved.